Pathology and Therapeutics for Pharmacists 4th Edition Ebook PDF download
Pathology and Therapeutics for Pharmacists 4th Edition Ebook PDF download THE RESPONSE TO the previous editions of this text have been favourable, and it has clearly fulfilled a need of our target audience. Consequently, we were delighted that the Pharmaceutical Press, who steered us so capably through the second edition and its several reprints, asked us to produce this third edition.
Since our last edition the important changes that have transformed pharmacotherapy are the rise of evidence based medicine (EBM) and the firm establishment of national and international therapeutic guidelines, usually based on careful meta-analyses of randomized controlled trials. These have frequently been issued by disease- specific organizations such as the British Hypertension Society, or generic bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Prescribing Centre in the UK.
Pathology and Therapeutics for Pharmacists 4th Edition Ebook PDF download These guidelines have been incorporated into this edition wherever avail- able, and have been a main focus of the update. However, as before, the overall intention remains to demonstrate how knowledge of the biomedical sciences of physiology, pathology and pharmacology underpins understanding of the rationale behind these recommendations.
The major advance in therapy has been the long awaited and much heralded advent of specifically designed ‘biological treatments’. These agents, fruits of the dramatic increase in our understanding of molecular biology and genetics, and the application of combinatorial methods in drug design, are finally starting to transform many areas of therapeutics, notably cancer and inflammatory disease.
Pathology and Therapeutics for Pharmacists 4th Edition Ebook PDF download Other changes are transforming the organiza- tion and delivery of clinical pharmacy. In the UK, in secondary care the role of consultant pharmacist is developing, while in primary care
itishopedthepharmacistprescribingandanew community pharmacist contract will give impe- tus to far greater involvement of pharmacists in patient care and management.
We have retained the format of the second edi- tion, but the text has been extensively reworked to improve clarity, coherence and uniformity. We have significantly reorganized and harmo- nized the sections and headings to improve con- sistency in structure and comprehension. These changes, together with a more detailed index, have enabled us to use an improved internal cross-referencing system. Where there are cross- references within a chapter, the reader is direc- ted to a closely-associated block of text or, if the reference is more remote, the page number is given. Cross-references outside a chapter give the chapter number, which together with the index should enable the material to be located quickly. In similar vein, the book has been divided into two sections. Part 1 (Chapters 1 and 2) covers essential introductory material. Part 2 (Chapters 3 to 14) deals with the various body systems and their diseases, arranged in the same order as the British National Formulary (BNF) wherever possible. We have added coverage of Thyroid disease in the Endocrine chapter, and a new chapter on Haematological disease. The use of drugs in renal impairment has been expanded in the Renal chapter. Evidence based therapeutic guidelines have been emphasized .